Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / CS
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
283K
-
Shares change
-
-17.5K
-
Total reported value, excl. options
-
$5.33M
-
Value change
-
-$320K
-
Number of buys
-
1
-
Number of sells
-
-4
-
Price
-
$18.85
Significant Holders of CHUGAI PHARMA UNSUP ADR - CS (CHGCY) as of Q4 2023
9 filings reported holding CHGCY - CHUGAI PHARMA UNSUP ADR - CS as of Q4 2023.
CHUGAI PHARMA UNSUP ADR - CS (CHGCY) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 283K shares
.
Largest 9 shareholders include TODD ASSET MANAGEMENT LLC (220K shares), RHUMBLINE ADVISERS (22.8K shares), PNC FINANCIAL SERVICES GROUP, INC. (19.3K shares), RIVERBRIDGE PARTNERS LLC (13.2K shares), GAMMA Investing LLC (5.52K shares), Tradition Wealth Management, LLC (1.35K shares), Operose Advisors LLC (535 shares), Accent Capital Management, LLC (400 shares), and Russell Investments Group, Ltd. (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.